| Reference |
|---|
Zheng P, Xiu Y, Chen Z, Yuan M, Li Y, Wang N, et al. Group 2 innate lymphoid cells resolve neuroinflammation following cerebral ischaemia. Stroke Vasc Neurol. 2023;8:424-434 pubmed publisher |
Sun X, Zhang C, Sun F, Li S, Wang Y, Wang T, et al. IL-33 promotes double negative T cell survival via the NF-κB pathway. Cell Death Dis. 2023;14:242 pubmed publisher |
Burganova G, Schonblum A, Sakhneny L, Epshtein A, Wald T, Tzaig M, et al. Pericytes modulate islet immune cells and insulin secretion through Interleukin-33 production in mice. Front Endocrinol (Lausanne). 2023;14:1142988 pubmed publisher |
Dai C, Chen H, Jiao M, Zhang N, Tang X, Fan A, et al. IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia. Clin Cosmet Investig Dermatol. 2023;16:639-650 pubmed publisher |
Slusarczyk P, Mandal P, Zurawska G, Niklewicz M, Chouhan K, Mahadeva R, et al. Impaired iron recycling from erythrocytes is an early hallmark of aging. elife. 2023;12: pubmed publisher |
Xu L, Wei C, Chen Y, Wu Y, Shou X, Chen W, et al. IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection. Nat Commun. 2022;13:6881 pubmed publisher |
Camacho D, Velez T, Hollinger M, Wang E, Howard C, Darnell E, et al. IRF4 expression by lung dendritic cells drives acute but not Trm cell-dependent memory Th2 responses. JCI Insight. 2022;7: pubmed publisher |
Mattei F, Andreone S, Spadaro F, Noto F, Tinari A, Falchi M, et al. Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes. iScience. 2022;25:105110 pubmed publisher |
Fujimoto M, Yokoyama M, Kiuchi M, Hosokawa H, Nakayama A, Hashimoto N, et al. Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis. Nat Commun. 2022;13:5408 pubmed publisher |
Jowett G, Read E, Roberts L, Coman D, Vil xe0 Gonz xe1 lez M, Zabinski T, et al. Organoids capture tissue-specific innate lymphoid cell development in mice and humans. Cell Rep. 2022;40:111281 pubmed publisher |
He D, Xu H, Zhang H, Tang R, Lan Y, Xing R, et al. Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function. Immunity. 2022;55:159-173.e9 pubmed publisher |
Nakajima T, Kanno T, Yokoyama S, Sasamoto S, Asou H, Tumes D, et al. ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice. J Exp Med. 2021;218: pubmed publisher |
Boothby I, Kinet M, Boda D, Kwan E, Clancy S, Cohen J, et al. Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin. Nature. 2021;599:667-672 pubmed publisher |
Miller J, Lingegowda H, Symons L, Bougie O, Young S, Lessey B, et al. IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis. JCI Insight. 2021;6: pubmed publisher |
Li C, Wang G, Sivasami P, Ramirez R, Zhang Y, Benoist C, et al. Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesity. Cell Metab. 2021;33:1610-1623.e5 pubmed publisher |
Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher |
Meiners J, Reitz M, R xfc diger N, Turner J, Heepmann L, Rudolf L, et al. IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation. PLoS Pathog. 2020;16:e1009121 pubmed publisher |
Zeis P, Lian M, Fan X, Herman J, Hernandez D, Gentek R, et al. In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors. Immunity. 2020;53:775-792.e9 pubmed publisher |
Gao Y, Luo C, Yao Y, Huang J, Fu H, Xia C, et al. IL-33 Alleviated Brain Damage via Anti-apoptosis, Endoplasmic Reticulum Stress, and Inflammation After Epilepsy. Front Neurosci. 2020;14:898 pubmed publisher |
Kienzl M, Hasenoehrl C, Valadez Cosmes P, Maitz K, Sarsembayeva A, Sturm E, et al. IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils. Oncoimmunology. 2020;9:1776059 pubmed publisher |
Lu Y, Basatemur G, Scott I, Chiarugi D, Clement M, Harrison J, et al. Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages. Immunity. 2020;52:782-793.e5 pubmed publisher |
Choi H, Won T, Hou X, Chen G, Bracamonte Baran W, Talor M, et al. Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis. Cell Rep. 2020;30:2989-3003.e6 pubmed publisher |
Hurrell B, Galle Treger L, Jahani P, Howard E, Helou D, Banie H, et al. TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity. Cell Rep. 2019;29:4509-4524.e5 pubmed publisher |
Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher |
Frisbee A, Saleh M, Young M, Leslie J, Simpson M, Abhyankar M, et al. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection. Nat Commun. 2019;10:2712 pubmed publisher |
Xiao Y, Huang X, Zhao Y, Chen F, Sun M, Yang W, et al. Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota. Cell Mol Gastroenterol Hepatol. 2019;8:21-36 pubmed publisher |
Kenswil K, Jaramillo A, Ping Z, Chen S, Hoogenboezem R, Mylona M, et al. Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Factor. Cell Rep. 2018;22:666-678 pubmed publisher |
Dalmas E, Lehmann F, Dror E, Wueest S, Thienel C, Borsigova M, et al. Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid Production. Immunity. 2017;47:928-942.e7 pubmed publisher |
Caslin H, McLeod J, Spence A, Qayum A, Kolawole E, Taruselli M, et al. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells. Cell Immunol. 2017;319:10-16 pubmed publisher |
Galle Treger L, Suzuki Y, Patel N, Sankaranarayanan I, Aron J, Maazi H, et al. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. Nat Commun. 2016;7:13202 pubmed publisher |
Billroth MacLurg A, Ford J, Rosenberg A, Miller J, Fowell D. Regulatory T Cell Numbers in Inflamed Skin Are Controlled by Local Inflammatory Cues That Upregulate CD25 and Facilitate Antigen-Driven Local Proliferation. J Immunol. 2016;197:2208-18 pubmed publisher |
Matta B, Reichenbach D, Zhang X, Mathews L, Koehn B, Dwyer G, et al. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. Blood. 2016;128:427-39 pubmed publisher |
Fu A, Hung K, Yuen M, Zhou X, Mak D, Chan I, et al. IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A. 2016;113:E2705-13 pubmed publisher |
Gomez Rodriguez J, Meylan F, Handon R, Hayes E, Anderson S, Kirby M, et al. Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun. 2016;7:10857 pubmed publisher |
Dépis F, Kwon H, Mathis D, Benoist C. Unstable FoxP3+ T regulatory cells in NZW mice. Proc Natl Acad Sci U S A. 2016;113:1345-50 pubmed publisher |
Bremser A, Brack M, Izcue A. Higher Sensitivity of Foxp3+ Treg Compared to Foxp3- Conventional T Cells to TCR-Independent Signals for CD69 Induction. PLoS ONE. 2015;10:e0137393 pubmed publisher |
Barlow J, Bellosi A, Hardman C, Drynan L, Wong S, Cruickshank J, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2012;129:191-8.e1-4 pubmed publisher |
Zaiss M, Kurowska Stolarska M, Böhm C, Gary R, Scholtysek C, Stolarski B, et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J Immunol. 2011;186:6097-105 pubmed publisher |
Miller A, Asquith D, Hueber A, Anderson L, Holmes W, McKenzie A, et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res. 2010;107:650-8 pubmed publisher |
